Cynosure Group LLC Has $873,000 Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Cynosure Group LLC increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 114.0% in the 4th quarter, HoldingsChannel.com reports. The firm owned 2,908 shares of the company’s stock after acquiring an additional 1,549 shares during the period. Cynosure Group LLC’s holdings in HCA Healthcare were worth $873,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Congress Wealth Management LLC DE increased its position in HCA Healthcare by 3.4% during the fourth quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company’s stock worth $312,000 after buying an additional 34 shares during the last quarter. Evergreen Private Wealth LLC grew its stake in shares of HCA Healthcare by 0.3% during the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company’s stock worth $3,838,000 after buying an additional 35 shares during the last quarter. Mediolanum International Funds Ltd increased its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company’s stock valued at $3,153,000 after buying an additional 36 shares during the period. Prairie Wealth Advisors Inc. raised its position in HCA Healthcare by 6.1% during the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company’s stock worth $210,000 after purchasing an additional 40 shares during the last quarter. Finally, Whittier Trust Co. boosted its holdings in HCA Healthcare by 3.6% in the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company’s stock valued at $359,000 after acquiring an additional 41 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on HCA. KeyCorp reduced their target price on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research note on Tuesday, January 7th. Barclays reduced their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a report on Monday, January 27th. Morgan Stanley reduced their price objective on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a research report on Tuesday, December 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $405.00 target price on shares of HCA Healthcare in a research note on Monday, January 27th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $385.67.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Stock Up 0.1 %

Shares of NYSE:HCA opened at $345.86 on Wednesday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The stock has a market capitalization of $85.15 billion, a price-to-earnings ratio of 15.74, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company’s fifty day moving average is $325.79 and its two-hundred day moving average is $340.25.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the prior year, the company earned $5.90 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were given a dividend of $0.72 per share. The ex-dividend date was Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.